XBiotech (id:8346 XBIT)
6.83 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/24/2024 6:42:15 PM)
Exchange closed, opens in 14 hours 47 minutes
About XBiotech
Market Capitalization 208.20M
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
| Headquarters (address) |
5217 Winnebago Lane Austin 78744 TX United States |
| Phone | 512 386 2900 |
| Website | https://www.xbiotech.com |
| Employees | 94 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | XBIT |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 3.60 - 9.96 |
| Market Capitalization | 208.20M |
| Dividend yield forward | 146.41 % |
| Dividend yield forward United States (ID:6, base:1864) | 4.13 % |
| P/E trailing | -8.43 |
| P/E forward | 52.54 |
| Price/Book | 1.08 |
| Beta | 1.41 |
| EPS | -1.08 |
| EPS United States (ID:6, base:3402) | 24.22 |
Forward Annual Dividend Yield
Forward Annual Dividend Yield: XBiotech has raised their dividend 146.41 years in a row. This is below the 41490.207800 year average in the 'Biotechnology' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: XBiotech has raised their dividend 146.41 years in a row. This is below the 41490.207800 year average in the 'Biotechnology' industry